Skip to main content

Reduced IL-33 plasma levels in aplastic anemia

Citations of this article
Mendeley users who have this article in their library.


Background: In this study, we aim to evaluate the balance of interleukin (IL)-33 and its soluble receptor sST2 in patients with aplastic anemia (AA). Methods: Plasma IL-33, IL-17 and sST2 levels were measured in patients with active AA (n=31), AA in remission (n=29) and in healthy subjects (n=30), using enzyme linked immunosorbent assays (ELISAs). Results: The results showed that sST2 and IL-17 levels were significantly elevated in patients with active AA when compared to control subjects, but IL-33 levels were significantly lower in AA patients, which resulted in elevated sST2/IL-33 ratios in patients with active disease. During remission stages, the levels of these cytokines were comparable to those of healthy controls. Conclusions: The elevated levels of sST2/IL-33 in the plasma during active stages of the disease suggest a possible role in the pathogenesis and course of AA.




Sun, M., Ma, H. feng, Che, Y. yun, & Cui, X. (2015). Reduced IL-33 plasma levels in aplastic anemia. Cancer Cell International, 15(1).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free